El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

GibsonTM.pdf (310.55 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2013-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/126477

Smoking, Variation In N-acetyltransferase 1 (nat1) And 2 (nat2), And Risk Of Non-hodgkin Lymphoma: A Pooled Analysis Within The Interlymph Consortium

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1007/s10552-012-0098-4

Resum

Studies of smoking and risk of non-Hodgkin lymphoma (NHL) have yielded inconsistent results, possibly due to subtype heterogeneity and/or genetic variation impacting the metabolism of tobacco-derived carcinogens, including substrates of the N-acetyltransferase enzymes NAT1 and NAT2. We conducted a pooled analysis of 5,026 NHL cases and 4,630 controls from seven case-control studies in the international lymphoma epidemiology consortium to examine associations between smoking, variation in the N-acetyltransferase genes NAT1 and NAT2, and risk of NHL subtypes. Smoking data were harmonized across studies, and genetic variants in NAT1 and NAT2 were used to infer acetylation phenotype of the NAT1 and NAT2 enzymes, respectively. Pooled odds ratios (ORs) and 95 % confidence intervals (95 % CIs) for risk of NHL and subtypes were calculated using joint fixed effects unconditional logistic regression models. Current smoking was associated with a significant 30 % increased risk of follicular lymphoma (n = 1,176) but not NHL overall or other NHL subtypes. The association was similar among NAT2 slow (OR 1.36; 95 % CI 1.07-1.75) and intermediate/rapid (OR 1.27; 95 % CI 0.95-1.69) acetylators (p (interaction) = 0.82) and also did not differ by NAT1*10 allelotype. Neither NAT2 phenotype nor NAT1*10 allelotype was associated with risk of NHL overall or NHL subtypes. The current findings provide further evidence for a modest association between current smoking and follicular lymphoma risk and suggest that this association may not be influenced by variation in the N-acetyltransferase enzymes.

Matèries

Malaltia de Hodgkin, Hàbit de fumar

Matèries (anglès)

Hodgkin's disease, Smoking

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

GIBSON, Todd m., SMEDBY, Karin e., SKIBOLA, Christine f., HEIN, David w., SLAGER, Susan l., SANJOSÉ LLONGUERAS, Silvia de, VAJDIC, Claire m., ZHANG, Yawei, CHIU, Brian c. h., WANG, Sophia s., HJALGRIM, Henrik, NIETERS, Alexandra, BRACCI, Paige m., KRICKER, Anne, ZHENG, Tongzhang, KOLAR, Carol, CERHAN, James r., DARABI, Hatef, BECKER, Nikolaus, CONDE, Lucía, HOLFORD, Theodore r., WEISENBURGER, Dennis d., ROOS, Anneclaire j. de, BUTTERBACH, Katja, RIBY, Jacques, COZEN, Wendy, BENAVENTE, Yolanda, PALMERS, Casey, HOLLY, Elizabeth a., SAMPSON, Joshua n., ROTHMAN, Nathaniel, ARMSTRONG, Bruce k., MORTON, Lindsay m.. Smoking, Variation In N-acetyltransferase 1 (nat1) And 2 (nat2), And Risk Of Non-hodgkin Lymphoma: A Pooled Analysis Within The Interlymph Consortium. _Cancer Causes & Control_. 2013. Vol. 24, núm. 1, pàgs. 125-134. [consulta: 3 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/126477]

Exportar metadades

JSON - METS

Compartir registre